Myriad Genetics
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
        • Documents & forms
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • FirstGene™
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Newsroom
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640
PORTALS ORDER
    Portals
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
        • Documents & forms
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • FirstGene™
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Newsroom
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640

Category: Patient Blog

Urology > Patient Blog > Page 2
  • Category
    • All
    • Patient Blog
    • Patient-Featured
    • Patients
    • Physician Blog
    • Prostate Cancer
    • Provider Blog
    • Providers
    • Urology
    • Video

Biomarker Testing: Empowering Patients in Prostate Cancer Management

July 14, 2023

Geoff McLennan, MPA, Prostate Cancer Patient and Advocate - July 2023 Welcome back to my blog series on helping patients understand prostate cancer. I hope ...

Continue Reading

Empowered by Genetic Testing: How MyRisk® Hereditary Cancer Testing Helps Take Preventive Measures

May 25, 2023

Larry underwent a radical prostatectomy when he was first diagnosed with prostate cancer at age 62. Although the surgery was successful in removing the cancer,...

Continue Reading

Understanding Prostate Cancer: A Guide for Men and Their Loved Ones

May 1, 2023

Prostate cancer is a very common disease, roughly 1 in 8 American men will be diagnosed with prostate cancer during their lifetime. Receiving a prostate cancer...

Continue Reading

Prostate Cancer Proactive Healthcare Steps

March 17, 2023

Author: Geoff McLennan, prostate cancer patient and advocate Every January since 1951 the American Cancer Society (ACS) has published an annual report about...

Continue Reading

Personalized Prostate Cancer Treatment: The Role of the Prolaris® Test

March 10, 2023

Prostate cancer is a common cancer affecting men, and historically the most common approach to treatment would be either surgery or radiation therapy. However,...

Continue Reading

American Cancer Society® Reports Increase in Late-Stage Prostate Cancer

February 3, 2023

Amid the great news reported recently by the American Cancer Society — that overall deaths from cancer have dropped by a third since 1991, saving nearly 4 mi...

Continue Reading

How is the Prostate Gleason Score Graded? Your Biopsy and Gleason Score Part 2

February 1, 2023

Geoff McLennan, Prostate Cancer Survivor and Advocate In part one of this blog series, I explained the different types of prostate biopsies availa...

Continue Reading

Types of Prostate Biopsies: Your biopsy and Gleason score Part 1

January 23, 2023

Geoff McLennan, Prostate Cancer Survivor and Advocate A urologist will usually, but not always, suggest a biopsy of your prostate when there is reason ...

Continue Reading

Prostate cancer can be hereditary, get peace of mind with Myriad Genetic Testing

January 13, 2023

https://myriad-1.wistia.com/medias/yff9ux0rmk When Tim Petracca was diagnosed with prostate cancer at age 63, he began to think about his extensive fa...

Continue Reading

Patient PSA Test Primer: Best times to test and how to prepare

January 6, 2023

Geoff McLennan, Prostate Cancer Survivor and Advocate As men enter, or race, into middle-age, and their doctors add another level of care, the first of ma...

Continue Reading

Prolaris® provides clarity for prostate cancer treatment decisions. A patient story.

December 12, 2022

Elevated PSA levels warning Tim Petracca was a healthy 63-year-old when he attended a regularly scheduled check up with his primary care physician ...

Continue Reading

Patient Prostate Cancer Journey Part 3: Shared Decision-Making Benefits to Prostate Cancer Treatment

December 1, 2022

A transparent, confident relationship with your urologist is important not only for your current health, but for your future health outcomes. The good new...

Continue Reading

Patient Prostate Cancer Journey Part 2: Getting to Active Surveillance

November 17, 2022

In my prior post, I described my surprising journey to an initial prostate diagnosis of hgpin, short for high-grade prostatic intraepithelial neoplasia. H...

Continue Reading

Patient Prostate Cancer Journey Part 1: A Urology Exam Reveals Unexpected Results

November 1, 2022

The day began positively average and uneventful. Dressed and ready for work, I mentioned to my wife, "I'll be home a bit later than usual - I have an appo...

Continue Reading

Can a genetic test improve prostate cancer treatment decisions? A patient story.

October 25, 2022

How can a prognostic test inform care plans for a patient with prostate cancer? Richard Tyus and his urologist worked together to find out. Elevate...

Continue Reading
  • 1
  • 2
  • 3
  • 4
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Newsroom
    • Blog
  • About
    • About Myriad
    • Careers
    • Contact us
  • Terms of Use
  • HIPAA Notice of Privacy Practices
  • Provider Portal Terms of Use
  • Privacy Notice
  • Patents
  • Health Privacy Notice
  • Compliance and Code of Conduct
  • Notice of Nondiscrimination and Discrimination Grievance Procedure
  • IT Security
  • Notice of Access to Language Assistance Services
  • Cookie Preferences
facebook linkedin x X/Twitter social network instagram youtube
  • © 2025 Myriad Genetics, Inc.

Locations

United States
Europe
Japan